Literature DB >> 29966632

Chronic Thromboembolic Pulmonary Hypertension.

Christopher J Mullin1, James R Klinger2.   

Abstract

Chronic thromboembolic pulmonary hypertension (CTEPH) is a distinct type of pulmonary hypertensive disease, characterized by incomplete or abnormal resolution of acute pulmonary embolism such that residual emboli become organized and fibrotic. CTEPH can occur in patients without a prior history of venous thromboembolism, and is diagnosed based on precapillary pulmonary hypertension on right heart catheterization with evidence of chronic emboli on ventilation/perfusion scan, chest imaging, or pulmonary angiogram. Pulmonary endarterectomy (PEA) is often curative, and results in improved survival. In patients for whom PEA is not feasible, medical therapy has been effective in improving hemodynamics and functional capacity.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CTEPH; Chronic thromboembolic pulmonary hypertension; Chronic thromboembolism; Pulmonary artery balloon angioplasty; Pulmonary embolism; Pulmonary endarterectomy; Pulmonary hypertension

Mesh:

Year:  2018        PMID: 29966632     DOI: 10.1016/j.hfc.2018.02.009

Source DB:  PubMed          Journal:  Heart Fail Clin        ISSN: 1551-7136            Impact factor:   3.179


  10 in total

1.  Complexities and complications of extreme obesity.

Authors:  Haval Ali; Udit Naik; Michelle McDonald; Mohammad Almosa; Karen Horn; Alexis Staines; Louis Maximilian Buja
Journal:  Autops Case Rep       Date:  2022-10-05

Review 2.  Connexins may play a critical role in cigarette smoke-induced pulmonary hypertension.

Authors:  Xiaojiang Qin; Anqi Gao; Xiaomin Hou; Xinrong Xu; Liangjin Chen; Lin Sun; Yuxuan Hao; Yiwei Shi
Journal:  Arch Toxicol       Date:  2022-03-27       Impact factor: 6.168

Review 3.  In situ Pulmonary Artery Thrombosis: A Previously Overlooked Disease.

Authors:  Yunshan Cao; Chao Geng; Yahong Li; Yan Zhang
Journal:  Front Pharmacol       Date:  2021-07-08       Impact factor: 5.810

Review 4.  Chronic Thromboembolic Pulmonary Hypertension: An Update.

Authors:  Barbara Ruaro; Elisa Baratella; Gaetano Caforio; Paola Confalonieri; Barbara Wade; Cristina Marrocchio; Pietro Geri; Riccardo Pozzan; Alessia Giovanna Andrisano; Maria Assunta Cova; Maurizio Cortale; Marco Confalonieri; Francesco Salton
Journal:  Diagnostics (Basel)       Date:  2022-01-19

5.  Effects of oral anticoagulant therapy in patients with pulmonary diseases.

Authors:  Jiying Lai; Shenghui Feng; Shuo Xu; Xin Liu
Journal:  Front Cardiovasc Med       Date:  2022-08-10

6.  The alterations in molecular markers and signaling pathways in chronic thromboembolic pulmonary hypertension, a study with transcriptome sequencing and bioinformatic analysis.

Authors:  Wenqing Xu; Mei Deng; Xiapei Meng; Xuebiao Sun; Xincao Tao; Dingyi Wang; Shuai Zhang; Yanan Zhen; Xiaopeng Liu; Min Liu
Journal:  Front Cardiovasc Med       Date:  2022-07-26

Review 7.  Molecular Pathways in Pulmonary Arterial Hypertension.

Authors:  Aangi J Shah; Mounica Vorla; Dinesh K Kalra
Journal:  Int J Mol Sci       Date:  2022-09-02       Impact factor: 6.208

Review 8.  Acute on Chronic Thromboembolic Pulmonary Hypertension: Case Series and Review of Management.

Authors:  Isabelle Opitz; Miriam Patella; Olivia Lauk; Ilhan Inci; Dominique Bettex; Thomas Horisberger; Reto Schüpbach; Dagmar I Keller; Thomas Frauenfelder; Nils Kucher; John Granton; Thomas Pfammatter; Marc de Perrot; Silvia Ulrich
Journal:  J Clin Med       Date:  2022-07-21       Impact factor: 4.964

9.  Evaluation of Effect of Curcumin on Psychological State of Patients with Pulmonary Hypertension by Magnetic Resonance Image under Deep Learning.

Authors:  Tingting Ma; Ziyuan Ma; Xiuping Zhang; Fubo Zhou
Journal:  Contrast Media Mol Imaging       Date:  2021-07-26       Impact factor: 3.161

10.  [Chronic exposure to altitude. Clinical characteristics and diagnosis].

Authors:  Luis E Santos-Martínez; Ricardo A Gómez-Tejada; Carla X Murillo-Jauregui; Rodrigo A Hoyos-Paladines; Carlos V Poyares-Jardim; Mauricio Orozco-Levi
Journal:  Arch Cardiol Mex       Date:  2021-11-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.